AIHealthcare

VantAI is a New York-based generative AI drug discovery company focused on modeling protein-protein interactions and proximity therapeutics to identify and design new molecular entities, including molecular glues, biologics, protein degraders, and small-molecule drugs. The company has collaborated with major biopharma partners and has positioned itself as an AI-native platform for difficult-to-drug targets in the healthcare and life sciences market.